Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #141, August 2019
Plaintiffs in the DePuy Pinnacle hip multidistrict litigation have asked a Texas federal judge to schedule a case management conference “to address outstanding issues concerning the status and management of unresolved cases in the MDL.”
A Pennsylvania federal judge has dismissed a Zostavax action, ruling that it is barred by the doctrine of res judicata because the court already awarded Merck summary judgment on the claims in a previous action on the basis of untimeliness.
A California man has sued Johnson & Johnson and its subsidiary Ethicon, accusing them of failing to warn patients and doctors that their recalled curved intraluminal surgical staplers were defectively manufactured and could cause serious injury and death.
Trial has begun in a lawsuit in which the California attorney general is accusing Johnson & Johnson and its subsidiary Ethicon of deceptively marketing its surgical mesh devices as safe while concealing a host of serious risks and complications, including permanent disability.
Issue #140, July 2019
A Louisiana federal judge has allowed two Taxotere permanent hair loss actions to proceed, ruling that the plaintiffs’ claims are timely and there are questions of fact as to whether the learned intermediary doctrine bars the negligence and failure-to-warn claims.
An Illinois federal judge has refused to reinstate a $3 million verdict in a Paxil suicide case despite a recent U.S. Supreme Court ruling in which it clarified the “clear evidence” standard in the context of whether the FDA would approve changes to a drug’s warning label.
An Ohio federal judge has remanded a Medtronic pacemaker case to state court for lack of federal question jurisdiction, finding there is no substantial federal issue because the state court will not have to decide whether any government action was proper or constitutional.
Claims against Nevro Corp. in connection with its implantable spinal cord stimulator are preempted by federal law because the plaintiff failed to plead state law product liability claims that parallel federal regulations, a Florida federal judge has ruled.
A California federal judge has dismissed a complaint accusing the makers of Cordarone (amiodarone) of marketing the anti-arrhythmic drug for off-label use, ruling that the plaintiff failed to cure the pleading defects previously identified by the court.
A New Jersey federal judge has remanded a Biomet M2a Magnum hip case to state court, ruling that the plaintiffs have asserted colorable claims against the non-diverse seller defendants, destroying diversity jurisdiction.